Discovery & Development Europe 2025: Formulation & Drug Delivery Congress
July 1-2, 2025
Basel, Switzerland

Invited lecture:
Oral Delivery Of Peptide And Protein Drugs – Oral Delivery of GLP-1 Analogues

Prof. Dr. A. Bernkop-Schnürch
more...

8th European Cyclodextrin Conference
September 9-12, 2025
Milano, Italy

Invited lecture:
Thiolated Cyclodextrins in Drug Delivery

Prof. Dr. A. Bernkop-Schnürch
more...

Formulation development is always an important step in the drug development process. We support our clients' projects from initial feasibility studies, to highly efficient, optimised drug delivery systems and product development. With our extensive experience, flexible services, and innovative technologies we are well positioned to put you ahead of your competitors. ThioMatrix provides clients with the experience, science, and know-how necessary to take their pharmaceutical products to the market. Drug delivery systems developed by ThioMatrix allow you to:

• improve the bioavailability of your drug
  
  
• improve the therapeutic efficacy
  
  
• reduce side effects
  
  
• improve stability
  
  
• achieve demanded delivery profiles that meet specific therapy requirements

  * zero-order release kinetics
  
  * sustained drug release

  * targeted drug release

• improve patient compliance
  
  
• generate additional intellectual property

Non-invasive drug delivery systems such as oral, nasal, buccal or vaginal drug delivery systems are highly favoured by patients. In comparison to parenteral delivery systems non-invasive delivery systems offer a much greater ease of application guaranteeing consequently a higher compliance and therapeutic efficacy.

Download a brochure

Thiomatrix joined the EU-project TENTACLE (101191747) focusing on the use of thiomers for in situ bioprinting.
more....